Veterinary Medicines

Metrocare 500 mg tablets for dogs and cats

Authorised
  • Metronidazole
Download as PDF

Product identification

Medicine name:
Metrocare 500 mg tablets for dogs and cats
Metrocare Vet. 500 mg tabletter
Active substance:
  • Metronidazole
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Metronidazole
    500.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01XD01
  • QP51AA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Available in:
  • Denmark
Package description:
  • 500 tablets - 50 PVC-Aluminium-Oriented polyamide -Aluminium blisters pack in a cardboard box.
  • 50 tablets - 5 PVC-Aluminium-Oriented polyamide -Aluminium blisters pack in a cardboard box.
  • 60 tablets - 6 PVC-Aluminium-Oriented polyamide -Aluminium blisters pack in a cardboard box.
  • 40 tablets - 4 PVC-Aluminium-Oriented polyamide -Aluminium blisters pack in a cardboard box.
  • 80 tablets - 8 PVC-Aluminium-Oriented polyamide -Aluminium blisters pack in a cardboard box.
  • 70 tablets - 7 PVC-Aluminium-Oriented polyamide -Aluminium blisters pack in a cardboard box.
  • 20 tablets - 2 PVC-Aluminium-Oriented polyamide -Aluminium blisters pack in a cardboard box.
  • 100 tablets - 10 PVC-Aluminium-Oriented polyamide -Aluminium blisters pack in a cardboard box.
  • 30 tablets - 3 PVC-Aluminium-Oriented polyamide -Aluminium blisters pack in a cardboard box.
  • 250 tablets - 25 PVC-Aluminium-Oriented polyamide -Aluminium blisters pack in a cardboard box.
  • 90 tablets - 9 PVC-Aluminium-Oriented polyamide -Aluminium blisters pack in a cardboard box.
  • 10 tablets - 1 PVC-Aluminium-Oriented polyamide -Aluminium blister pack in a cardboard box.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ecuphar
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lelypharma B.V.
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 60796
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0239/002
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Hungary
  • Ireland
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (, TABLETTER 250 MG OG 500 MG)
Published on: 4/05/2022
Download

Combined File of all Documents

English (PDF)
Published on: 29/04/2025
Download